IRIS
MEGNA, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 15.785
NA - Nord America 11.684
EU - Europa 10.063
SA - Sud America 1.902
Continente sconosciuto - Info sul continente non disponibili 686
AF - Africa 376
OC - Oceania 24
AN - Antartide 1
Totale 40.521
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.153
SG - Singapore 6.764
RU - Federazione Russa 4.398
CN - Cina 3.302
VN - Vietnam 2.278
DE - Germania 1.871
IT - Italia 1.693
BR - Brasile 1.538
HK - Hong Kong 1.245
FR - Francia 560
IN - India 507
BD - Bangladesh 485
NL - Olanda 336
KR - Corea 292
JP - Giappone 263
CA - Canada 248
GB - Regno Unito 246
FI - Finlandia 205
IE - Irlanda 162
AR - Argentina 141
MX - Messico 139
UA - Ucraina 101
IQ - Iraq 89
ZA - Sudafrica 89
CI - Costa d'Avorio 84
PL - Polonia 83
ES - Italia 79
SE - Svezia 73
EC - Ecuador 64
PH - Filippine 62
ID - Indonesia 61
PK - Pakistan 56
TH - Thailandia 56
TR - Turchia 55
AT - Austria 50
TW - Taiwan 42
CO - Colombia 40
MA - Marocco 37
BG - Bulgaria 30
VE - Venezuela 28
PY - Paraguay 26
JM - Giamaica 24
KE - Kenya 24
LT - Lituania 24
MY - Malesia 24
SA - Arabia Saudita 23
CL - Cile 22
EG - Egitto 22
CR - Costa Rica 21
PE - Perù 19
UZ - Uzbekistan 19
JO - Giordania 18
TT - Trinidad e Tobago 18
AU - Australia 17
RO - Romania 17
CZ - Repubblica Ceca 16
TN - Tunisia 16
UY - Uruguay 16
OM - Oman 15
BE - Belgio 14
DZ - Algeria 13
ET - Etiopia 13
AE - Emirati Arabi Uniti 12
CH - Svizzera 12
DO - Repubblica Dominicana 12
GR - Grecia 12
HN - Honduras 12
BB - Barbados 11
NP - Nepal 11
DK - Danimarca 10
IL - Israele 10
RS - Serbia 10
AZ - Azerbaigian 9
CM - Camerun 9
IR - Iran 9
KZ - Kazakistan 9
LB - Libano 9
NI - Nicaragua 9
PT - Portogallo 9
PA - Panama 8
SC - Seychelles 8
SN - Senegal 8
BO - Bolivia 7
CG - Congo 7
SY - Repubblica araba siriana 7
AL - Albania 6
AM - Armenia 6
GT - Guatemala 6
HR - Croazia 6
KH - Cambogia 6
PS - Palestinian Territory 6
SV - El Salvador 6
CY - Cipro 5
EE - Estonia 5
HU - Ungheria 5
KG - Kirghizistan 5
BH - Bahrain 4
EU - Europa 4
LA - Repubblica Popolare Democratica del Laos 4
LV - Lettonia 4
Totale 39.724
Salva come PNG Salva come JPEG
Città #
Singapore 3.357
San Jose 1.998
Hefei 1.311
Ashburn 1.268
Hong Kong 1.184
Moscow 1.137
Chandler 688
Beijing 671
Ho Chi Minh City 657
Santa Clara 654
Hanoi 516
Krefeld 387
Lauterbourg 348
Los Angeles 338
The Dalles 332
Seoul 256
Amsterdam 251
Naples 250
Tokyo 228
Kochi 222
New York 211
Dallas 204
Napoli 188
Boston 180
Bad Bellingen 171
Buffalo 170
Millbury 168
Milan 159
Redondo Beach 158
Council Bluffs 150
São Paulo 150
Lawrence 146
Des Moines 139
Munich 114
Rome 110
Da Nang 93
Frankfurt am Main 93
Nanjing 87
Seattle 84
Orem 78
Houston 76
Haiphong 75
Helsinki 73
Mexico City 72
Brooklyn 69
Chicago 66
Wilmington 66
Dublin 63
Toronto 61
Atlanta 58
Princeton 58
Montreal 57
Chennai 53
Rio de Janeiro 53
Warsaw 53
Falkenstein 52
London 51
San Francisco 48
Denver 46
Nuremberg 46
Dong Ket 44
Fairfield 44
Turku 44
Düsseldorf 43
Boardman 41
Guangzhou 41
Biên Hòa 39
Washington 39
Lappeenranta 38
Phoenix 37
Menlo Park 34
Hải Dương 33
Johannesburg 33
Poplar 32
Stockholm 32
Woodbridge 31
Can Tho 30
Baghdad 28
Belo Horizonte 28
Nanchang 28
Brasília 27
Kronberg 27
Mumbai 27
Sofia 27
Shanghai 26
Ottawa 24
Curitiba 23
Guayaquil 23
Nairobi 23
Paris 23
Pune 23
Arezzo 22
Shenyang 21
Ankara 20
Bengaluru 20
Campinas 20
Dhaka 20
Porto Alegre 20
Kingston 19
Manchester 19
Totale 21.275
Salva come PNG Salva come JPEG
Nome #
Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study 402
Multi-failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohort 382
Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses – IL PSO (Italian landscape psoriasis) 374
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study—IL PSO (ITALIAN LANDSCAPE PSORIASIS) 363
A case of aquagenic wrinkling of the palms 246
Very low-calorie ketogenic diet (VLCKD) in patients with psoriasis and obesity: an update for dermatologists and nutritionists 207
A case of the co-existence of subcorneal pustular dermatosis and pyoderma gangrenosum and a review of the literature 201
"Active" photoprotection: sunscreens with DNA repair enzymes. A review of the literature 184
Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications 182
Therapeutic update of biologics and small molecules for scalp psoriasis: a systematic review 179
An indolent nasal form of primary cutaneous CD8-positive peripheral T-cell lymphoma not otherwise specified successfully treated with local radiation therapy- a new subtype? 173
Psoriasis and sport: a new ally? 172
Guselkumab, Risankizumab, and Tildrakizumab in the Management of Psoriasis: A Review of the Real-World Evidence 171
Generalized violaceous maculopapular rash and multiple verrucous nodules on the testes: a case of secondary syphilis misdiagnosed as lymphoma 166
Skin diseases and visual arts 161
Vitamin D and its role in psoriasis: An overview of the dermatologist and nutritionist 161
Efficacy and safety of risankizumab in psoriasis patients who failed anti‐IL‐17, anti‐12/23 and/or anti IL‐23: preliminary data of a real‐life 16‐week retrospective study 159
The Role of Thermal Water in Chronic Skin Diseases Management: A Review of the Literature 159
Persistent candidiasis infection during anti‐ IL ‐17 treatment for plaque psoriasis requiring biologic discontinuation: a case series and literature review 158
What's new about atopic dermatitis and sporting activity 158
Generalized Pustular Psoriasis rapidly and successfully treated with Ixekizumab in a Caucasian patient 158
The effect of the ketogenic diet on Acne: Could it be a therapeutic tool? 156
Management of Psoriasis Patients with Serious Infectious Diseases 155
Cutaneous leucocytoclastic vasculitis during secukinumab treatment 155
Possible role of BMP-4 in the hyper-pigmentation of psoriatic plaques after anti-TNF-α treatment 154
Psoriasis Features in Patients with Inflammatory Bowel Disease 153
Chronic inducible urticarias in children 152
Injection site reactions resulting from the use of biological therapy in the treatment of moderate-to-severe plaque psoriasis 150
Adult atopic dermatitis: a review 150
Hidradenitis suppurativa: guidelines of the Italian Society of Dermatology and Venereology (SIDeMaST) for the use of anti-TNF-α agents. 150
Hypersensitivity reaction to certolizumab pegol in a patient affected by psoriatic arthritis 149
Efficacy and Safety of Anti-TNF Biosimilars for Psoriasis in Pediatric and Geriatric Populations: A 72-Week Real-Life Study 146
Appearances may be deceiving 144
Calcipotriol/betamethasone dipropionate formulations for psoriasis: an overview of the options and efficacy data 144
Predictive Factors for Super Responder Status and Long-Term Effectiveness of Guselkumab in Psoriasis: A Multicenter Retrospective Study 142
QuantiFERON TB‐gold conversion rate among psoriasis patients under biologics: a 9‐year retrospective study 140
Psoriasis in a cohort of patients with common variable immunodeficiency 139
Skin diseases and tattoos: A five-year experience 139
Cutaneus sarcoidosis small-fiber neuropathy resembling leprosy: a case report 139
A case of psoriatic alopecia secondary to certolizumab pegol: clinical and trichoscopic evaluation 139
Anterior Cervical Hypertrichosis: A Case Report and Review of the Literature. 138
The Impact of Psoriasis Treatments on the Risk of Skin Cancer: A Narrative Review 137
Acne prevalence in 9 to 14-year-old old patients attending pediatric ambulatory clinics in Italy 137
Is there any association between psoriasis, psoriatic arthritis and thyroid autoimmunity? 137
Long-Term Efficacy and Safety of Guselkumab in Psoriasis Patients Who Failed Anti-IL17: A Two-Year Real-Life Study 136
L'avvento degli inibitori delle proteasi nella terapia dell'infezione da epatite C: Reazioni avverse dermatologiche 136
Psoriatic arthritis and psoriasis: differential diagnosis 136
Apremilast efficacy and safety in elderly psoriasis patients over a 48-weeks period 136
Real-world practice indirect comparison between guselkumab, risankizumab and tildrakizumab: results from an Italian 28-week retrospective study 136
Tattooing and hidradenitis suppurativa: stigmatization and camouflage 135
Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience 135
Neutrophilic dermatosis in pregnancy: An uncommon course 135
Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears 135
The use of ChatGPT in the dermatological field: a narrative review 134
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: focus on pediatric patients 134
Effectiveness and Safety of Tildrakizumab in Psoriasis Patients Who Failed Anti-IL17 Treatment: A 28-Week Real-Life Study 134
Systemic treatment for psoriasis and malignancies: A real risk? 134
Eczematous drug eruption in patients with psoriasis under anti‐interleukin‐17A: does interleukin‐22 play a key role? 134
Corrigendum: A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab (Clin Cosmet Investig Dermatol. (2023), 16, (3503–3507), 10.2147/CCID.S447123) 133
Insulin Resistance and Skin Diseases 133
Immunocytometric analysis of COVID patients: A contribution to personalized therapy? 132
Bimekizumab for the Treatment of Plaque Psoriasis With Involvement of Genitalia: A 16-Week Multicenter Real-World Experience - IL PSO (Italian Landscape Psoriasis) 131
16-year real-life study on the prevalence of mycoses in a paediatric population 131
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients 130
Infantile Acute Generalized Pustular Psoriasis: A Case Report 130
Erythrodermic Pityriasis Rubra Pilaris treatment: two case reports and literature review 130
Dermoscopic patterns of intradermal naevi 130
Ciprofloxacin-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) in a psoriasis patient 130
The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review 129
Waste exposure and skin diseases 129
A case of severe psoriatic arthritis with hands flexion contracture and palmar psoriasis successfully treated with guselkumab 128
The impact of COVID ‐19 infection on psoriatic patients treated with biologics: an Italian experience 128
Photodynamic Therapy and Skin Appendage Disorders: A Review 128
Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study 128
Pyoderma gangrenosum successfully treated with topical tacrolimus 128
Intralesional Methotrexate for the Treatment of Keratoacanthoma: The Neapolitan Experience 128
Erythrodermic psoriasis successfully and rapidly treated with brodalumab: report of two cases 128
Melanoma frequency among symmetrical Spitzoid-looking lesions: a retrospective study 127
Impact of current anti-psoriatic systemic treatments on male and female fertility: what the endocrinologist needs to know 127
Ixekizumab: an efficacious treatment for both psoriasis and hidradenitis suppurativa 127
A Case of Steatocystoma Multiplex in a Psoriatic Patient during Treatment with Anti-IL-12/23 126
Biologic Therapies, Psoriasis, and COVID-19: Our Experience at the Psoriasis Unit of the University of Naples Federico II 126
Psoriatic Alopecia and Paradoxical Psoriasis Induced by Adalimumab Successfully Treated with Certolizumab: Clinical, Trichoscopic, and in vivo Reflectance Confocal Microscopy Features 125
Irisin, a novel metabolic biomarker in hidradenitis suppurativa: correlation with clinical responsivity to anti-TNF-α therapy 125
Melanocytic nevi in children of southern Italy: dermoscopic, constitutional, and environmental factors. 125
Medical and Surgical Treatment of Hidradenitis Suppurativa: A Review 125
QuantiFERON TB-gold conversion is not uncommon in psoriasis patients under anti-TNF-α 125
Garbage and skin diseases related risk. 124
A case of Stewart-Treves Syndrome of the lower limbs: The usefulness of dermoscopy 124
Hidradenitis Suppurativa and JAK Inhibitors: A Review of the Published Literature 123
Efficacy of JAK inhibitors in the treatment of psoriasiform atopic dermatitis 123
Chronic hand Eczema: Is IL-36á helpful in diagnosis and classification? 123
Teledermatology for acne during COVID-19: high patients' satisfaction in spite of the emergency 123
Rowell Syndrome: A Diagnostic Challenge 123
Hidradenitis Suppurativa Cancer Risk: A Review of the Literature 122
Drug safety evaluation of tildrakizumab for psoriasis: a review of the current knowledge 122
Leg paralysis after photodynamic therapy for Lymphomatoid Papulosis: a case report 122
Drug safety evaluation of ixekizumab for psoriasis: a review of the current knowledge 121
Aquagenic wrinkling of the palms: a case report and literature review 121
Teledermatology: a useful tool also after Covid-19 era? 121
Totale 15.065
Salva come PNG Salva come JPEG
Categoria #
all - tutte 131.047
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 131.047
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.279 0 32 21 44 39 52 30 92 155 103 219 492
2022/20232.027 234 168 66 93 211 201 72 207 311 254 165 45
2023/20243.132 101 238 225 143 111 213 58 187 1.287 73 344 152
2024/202510.538 468 590 81 85 266 587 980 769 802 1.378 3.645 887
2025/202620.942 2.170 2.269 2.190 2.030 3.066 798 2.167 1.303 2.314 1.125 679 831
2026/20271.128 758 370 0 0 0 0 0 0 0 0 0 0
Totale 40.521